These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 34887945)

  • 1. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.
    Chao TF; Joung B; Takahashi Y; Lim TW; Choi EK; Chan YH; Guo Y; Sriratanasathavorn C; Oh S; Okumura K; Lip GYH
    J Arrhythm; 2021 Dec; 37(6):1389-1426. PubMed ID: 34887945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Chao TF; Joung B; Takahashi Y; Lim TW; Choi EK; Chan YH; Guo Y; Sriratanasathavorn C; Oh S; Okumura K; Lip GYH
    Thromb Haemost; 2022 Jan; 122(1):20-47. PubMed ID: 34773920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.
    Chiang CE; Okumura K; Zhang S; Chao TF; Siu CW; Wei Lim T; Saxena A; Takahashi Y; Siong Teo W
    J Arrhythm; 2017 Aug; 33(4):345-367. PubMed ID: 28765771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
    Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
    Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.
    Chiang CE; Wu TJ; Ueng KC; Chao TF; Chang KC; Wang CC; Lin YJ; Yin WH; Kuo JY; Lin WS; Tsai CT; Liu YB; Lee KT; Lin LJ; Lin LY; Wang KL; Chen YJ; Chen MC; Cheng CC; Wen MS; Chen WJ; Chen JH; Lai WT; Chiou CW; Lin JL; Yeh SJ; Chen SA
    J Formos Med Assoc; 2016 Nov; 115(11):893-952. PubMed ID: 27890386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and treatment of atrial fibrillation in Asian cities: 1-year review of the Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.
    Tse HF; Teo WS; Siu CW; Chao TF; Park HW; Shimizu W; Wong YK; Lip GYH
    Europace; 2022 Dec; 24(12):1889-1898. PubMed ID: 35025986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P;
    Eur Heart J; 2017 Jul; 38(27):2137-2149. PubMed ID: 27282612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry.
    Bucci T; Shantsila A; Romiti GF; Teo WS; Chao TF; Shimizu W; Boriani G; Tse HF; Krittayaphong R; Lip GYH
    JACC Asia; 2024 Jan; 4(1):59-69. PubMed ID: 38222252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
    Chao TF; Tse HF; Teo WS; Park HW; Shimizu W; Chen SA; Lip GYH;
    Eur J Clin Invest; 2022 Oct; 52(10):e13825. PubMed ID: 35700114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.
    Chan NY; Orchard J; Agbayani MJ; Boddington D; Chao TF; Johar S; John B; Joung B; Krishinan S; Krittayaphong R; Kurokawa S; Lau CP; Lim TW; Linh PT; Long VH; Naik A; Okumura Y; Sasano T; Yan B; Raharjo SB; Hanafy DA; Yuniadi Y; Nwe N; Awan ZA; Huang H; Freedman B
    J Arrhythm; 2022 Feb; 38(1):31-49. PubMed ID: 35222749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
    Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
    Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
    Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asian strategy for stroke prevention in atrial fibrillation.
    Chiang CE; Wang KL; Lin SJ
    Europace; 2015 Oct; 17 Suppl 2():ii31-9. PubMed ID: 26842113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry.
    Bucci T; Proietti M; Shantsila A; Romiti GF; Teo WS; Park HW; Shimizu W; Tse HF; Lip GYH; Chao TF;
    JACC Asia; 2023 Aug; 3(4):580-591. PubMed ID: 37614548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anesthesiologists Guide to the 2019 AHA/ACC/HRS Focused Update for the Management of Patients With Atrial Fibrillation.
    Dalia AA; Kuo A; Vanneman M; Crowley J; Elhassan A; Lai Y
    J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1925-1932. PubMed ID: 31561986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke prevention in atrial fibrillation.
    Lip GYH; Gue Y; Zhang J; Chao TF; Calkins H; Potpara T
    Trends Cardiovasc Med; 2022 Nov; 32(8):501-510. PubMed ID: 34619337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.